Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults

Clinical trial NCT05972733 · COMPLETED

Trial details

NCT number: NCT05972733
Sponsor: HilleVax
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastroenteritis

Start date: 2023-08-01
Primary completion: 2023-08-14
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.